Data / Drug companies / Fluoroquinolone Antibacterial
Fluoroquinolone Antibacterial drugs: 14 drugs from 79 companies in the FDA NDC directory
Fluoroquinolone Antibacterial is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 262 products in this class from 79 companies, covering 14 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 79Companies
- 262Products
- 14Drugs by generic name
Drugs in the Fluoroquinolone Antibacterial class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Ciprofloxacin | 77 | 41 |
| Ciprofloxacin hydrochloride | 75 | 36 |
| Moxifloxacin hydrochloride | 25 | 20 |
| Moxifloxacin | 23 | 19 |
| Ciprofolxacin | 28 | 15 |
| Ciprofloxacin and dexamethasone | 14 | 12 |
| Ciprofloxacin hydrochloride and hydrocortisone | 5 | 5 |
| Moxifloxacin ophthalmic | 3 | 3 |
| Moxifloxacin hydrochloride tablets, 400 mg | 2 | 3 |
| Ciprofloxacin tablets | 4 | 2 |
| Moxifloxacin ophthalmic solution | 2 | 2 |
| Delafloxacin meglumine | 2 | 1 |
| Ciprofloxacin hcl | 1 | 1 |
| Ciprofloxacin hydrochloride and dexamethasone | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 23 | tablet, film coated; solution/ drops | Generic drugs (ANDA) | May 23, 2024 |
| NuCare Pharmaceuticals,Inc. | 19 | tablet; solution/ drops | Generic drugs (ANDA) | October 1, 2023 |
| PD-Rx Pharmaceuticals, Inc. | 16 | tablet, film coated; tablet | Generic drugs (ANDA) | May 23, 2024 |
| Bryant Ranch Prepack | 14 | tablet, film coated; tablet | Generic drugs (ANDA) | October 1, 2023 |
| Redpharm Drug | 14 | solution/ drops; tablet, film coated | Generic drugs (ANDA) | March 27, 2025 |
| Direct_Rx | 9 | tablet, film coated; tablet | Generic drugs (ANDA) | June 5, 2025 |
| Remedyrepack Inc. | 9 | tablet, film coated; tablet | Generic drugs (ANDA) | August 27, 2025 |
| Preferred Pharmaceuticals Inc. | 7 | tablet, film coated; tablet | Generic drugs (ANDA) | July 31, 2026 |
| Advanced Rx of Tennessee, LLC | 6 | solution/ drops; tablet, film coated | Generic drugs (ANDA) | March 20, 2025 |
| Aurobindo Pharma Limited | 6 | tablet, film coated | Generic drugs (ANDA) | March 27, 2025 |
| Asclemed USA, Inc. | 5 | tablet; solution | Generic drugs (ANDA) | October 1, 2023 |
| Aurobindo Pharma Limited | 5 | tablet, film coated; solution/ drops | Generic drugs (ANDA) | October 4, 2017 |
| PD-Rx Pharmaceuticals, Inc. | 5 | tablet; tablet, film coated | Generic drugs (ANDA) | October 10, 2009 |
| Sportpharm LLC | 5 | tablet; suspension/ drops | Generic drugs (ANDA) | October 1, 2023 |
| Bryant Ranch Prepack | 4 | tablet, film coated; solution/ drops | Generic drugs (ANDA) | October 1, 2023 |
| Chartwell RX, LLC | 4 | tablet, film coated | Generic drugs (ANDA) | April 13, 2021 |
| Coupler LLC | 4 | tablet; tablet, film coated | Generic drugs (ANDA) | August 4, 2026 |
| Golden State Medical Supply, Inc. | 4 | tablet, film coated; solution/ drops | Generic drugs (ANDA) | June 30, 2017 |
| Hawaii Repack, Inc. | 4 | tablet, film coated; solution | Generic drugs (ANDA) | November 1, 2018 |
| Proficient Rx LP | 4 | tablet; tablet, film coated | Generic drugs (ANDA) | May 23, 2024 |
| St. Mary's Medical Park Pharmacy | 4 | tablet; tablet, coated | Generic drugs (ANDA) | September 17, 2026 |
| Alembic Pharmaceuticals Inc. | 3 | solution/ drops; suspension/ drops | Generic drugs (ANDA) | November 2, 2026 |
| Amneal Pharmaceuticals NY LLC | 3 | tablet, film coated | Generic drugs (ANDA) | February 29, 2024 |
| Bryant Ranch Prepack | 3 | tablet, film coated | Generic drugs (ANDA) | March 5, 2014 |
| Carlsbad Technology, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | October 10, 2009 |
| Northwind Health Company, LLC | 3 | tablet, film coated; tablet, coated | Generic drugs (ANDA) | March 17, 2023 |
| Rising Pharma Holdings, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | September 10, 2004 |
| Umasuto, LLC | 3 | tablet | Generic drugs (ANDA) | March 5, 2025 |
| Westminster Pharmaceuticals, LLC | 3 | tablet, film coated | Generic drugs (ANDA) | May 23, 2024 |
| Alembic Pharmaceuticals Limited | 2 | solution/ drops; suspension/ drops | Generic drugs (ANDA) | October 15, 2026 |
| American Health Packaging | 2 | tablet, film coated | Generic drugs (ANDA) | May 3, 2026 |
| Bayer HealthCare Pharmaceuticals Inc. | 2 | tablet, film coated | New drug applications (NDA) | October 22, 1987 |
| Hikma Pharmaceuticals USA Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | June 9, 2004 |
| Hospira, Inc. | 2 | injection, solution | Generic drugs (ANDA) | June 30, 2023 |
| Lupin Pharmaceuticals, Inc. | 2 | solution; solution/ drops | Generic drugs (ANDA) | February 13, 2020 |
| Major Pharmaceuticals | 2 | tablet, film coated | Generic drugs (ANDA) | March 8, 2024 |
| Melinta Therapeutics, LLC | 2 | tablet; injection, powder, lyophilized, for solution | New drug applications (NDA) | June 19, 2017 |
| Method Pharmaceuticals, LLC | 2 | tablet, coated | Generic drugs (ANDA) | August 12, 2020 |
| Northwind Health Company, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | February 12, 2026 |
| NuCare Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | September 10, 2004 |
| QPharma, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | April 26, 2007 |
| Sandoz Inc | 2 | suspension/ drops; ointment | New drug applications (NDA) | March 15, 1999 |
| Sandoz Inc | 2 | suspension/ drops | Authorized generics (NDA) | August 10, 2020 |
| Solco Healthcare US, LLC | 2 | tablet | Generic drugs (ANDA) | October 1, 2023 |
| Upsher-Smith Laboratories, LLC | 2 | suspension; solution | Generic drugs (ANDA) | January 6, 2026 |
| Yiling Pharmaceutical, Inc. | 2 | tablet, coated | Generic drugs (ANDA) | July 13, 2019 |
| Advagen Pharma Ltd | 1 | solution | Generic drugs (ANDA) | March 16, 2022 |
| American Health Packaging | 1 | tablet, film coated | Generic drugs (ANDA) | March 19, 2014 |
| Amneal Pharmaceuticals of New York LLC | 1 | suspension/ drops | Generic drugs (ANDA) | March 26, 2024 |
| Apotex Corp. | 1 | solution/ drops | Generic drugs (ANDA) | July 1, 2017 |
| Armas Pharmaceuticals Inc. | 1 | suspension/ drops | Generic drugs (ANDA) | November 1, 2023 |
| AvPAK | 1 | tablet, film coated | Generic drugs (ANDA) | July 22, 2016 |
| Camber Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | March 2, 2023 |
| Cardinal Health 107, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | October 17, 2025 |
| Cosette Pharmaceuticals, Inc. | 1 | suspension/ drops | Generic drugs (ANDA) | December 4, 2025 |
| Dr. Reddy's Laboratories Inc. | 1 | suspension/ drops | Generic drugs (ANDA) | August 10, 2020 |
| Fosun Pharma USA Inc. | 1 | solution/ drops | Generic drugs (ANDA) | August 24, 2020 |
| Fresenius Kabi USA, LLC | 1 | injection, solution | New drug applications (NDA) | March 18, 2015 |
| Genus Lifesciences | 1 | solution/ drops | Generic drugs (ANDA) | December 1, 2024 |
| Golden State Medical Supply, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | June 9, 2004 |
| Harrow Eye, LLC | 1 | solution/ drops | New drug applications (NDA) | July 1, 2024 |
| Hp Halden Pharma As | 1 | injection, solution | New drug applications (NDA) | August 2, 2017 |
| Kesin Pharma Corporation | 1 | tablet, film coated | Generic drugs (ANDA) | December 12, 2025 |
| Leading Pharma, LLC | 1 | solution | Generic drugs (ANDA) | November 1, 2018 |
| Lifestar Pharma LLC | 1 | solution/ drops | Generic drugs (ANDA) | January 27, 2025 |
| Macleods Pharmaceuticals Limited | 1 | tablet, film coated | Generic drugs (ANDA) | March 2, 2026 |
| Mylan Institutional LLC | 1 | injection, solution | Generic drugs (ANDA) | October 3, 2017 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 1 | tablet, film coated | Generic drugs (ANDA) | March 27, 2025 |
| NorthStar Rx LLC | 1 | suspension/ drops | Generic drugs (ANDA) | August 1, 2022 |
| ProPharma Distribution | 1 | injection, solution | Generic drugs (ANDA) | December 1, 2022 |
| Proficient Rx LP | 1 | tablet, film coated | Generic drugs (ANDA) | April 26, 2007 |
| Rising Pharma Holdings, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | March 4, 2014 |
| Sagent Pharmaceuticals | 1 | injection, solution | Generic drugs (ANDA) | December 15, 2022 |
| Sentiss Pharmaceuticals LLC | 1 | suspension/ drops | Generic drugs (ANDA) | April 16, 2026 |
| Solaris Pharma Corporation | 1 | tablet, film coated | Generic drugs (ANDA) | December 12, 2025 |
| Somerset Therapeutics, LLC | 1 | solution/ drops | Generic drugs (ANDA) | November 25, 2024 |
| Sun Pharmaceutical Industries, Inc. | 1 | suspension/ drops | Generic drugs (ANDA) | September 1, 2022 |
| Teva Pharmaceuticals USA, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | November 1, 2006 |
| Verityrx, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | May 23, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 120 | 45.8% |
| Tablet | 47 | 17.9% |
| Solution/ drops | 36 | 13.7% |
| Suspension/ drops | 19 | 7.3% |
| Tablet, coated | 16 | 6.1% |
| Solution | 14 | 5.3% |
| Injection, solution | 7 | 2.7% |
| Suspension | 1 | 0.4% |
| Ointment | 1 | 0.4% |
| Injection, powder, lyophilized, for solution | 1 | 0.4% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.